Diferencias de género en pacientes que acuden a una consulta hospitalaria de deshabituación tabáquica / Gender differences of patients who come to the smoking cessation hospital visit

OBJETIVO: Evaluar diferencias de género en los pacientes que acuden a una consulta hospitalaria de deshabituación tabáquica analizando la abstinencia a seis meses. MÉTODO: Recogida retrospectiva durante dos años de los datos de una consulta de tabaco, realizándose un análisis descriptivo de la muestra. Se realizó un contraste de hipótesis para evaluar diferencias según género y un análisis de regresión logística para encontrar factores predictores de abstinencia a los seis meses. RESULTADOS: Se incluyeron 95 pacientes, 47 (49,47%) mujeres y 48 (50,53%) hombres. Solo 67 acudieron a la última visita. La edad media fue de 57,89 años. El tratamiento más utilizado fue la vareniclina (51,58%), seguido de TSN (34,74%). En 23 pacientes no se pautó medicación. El porcentaje global de éxito fue del 25,26% (n = 24). En pacientes sin medicación, del 34,78% (n = 8) y en los que se utilizó un tratamiento combinado del 36,36% (n = 4). Se dividió la muestra en dos grupos de edad, ≤ 55 y > 55 años. No se observaron diferencias significativas de género. Sí se observaron mejores tasas de abandono a mayor edad y mayor puntuación en la escala de motivación. CONCLUSIONES: · No se observan diferencias en las tasas de abandono en función del género. · El éxito en los intentos de abandono aumenta con la edad y con alta motivación

OBJECTIVE: To evaluate gender differences in patients to come to a smoking cessation hospital visit, analyzing abstinence at six months. METHOD: Retrospective collection of two years of the data from a smoking cessation consultation, carrying out a descriptive analysis of the sample. A contrast hypothesis was done to evaluate the gender differences and a logistic regression analysis to find predictor factors of abstinence at six months. RESULTS: A total of 95 patients, 47 (49.47%) women and 48 (50.53%) men were included. Only 67 came to the final visit. Mean age was 57.89 years. The treatment used most was varenicline (51.58%) followed by NRT (34.74%). No medication was prescribed in 23 patients. Overall percentage of success was 25.26% (n = 24). Success in patients without medication was 34.78% (n = 8) and those who used a combined treatment was 36.36% (n = 4). The sample was divided into two age groups ≤ 55 and > 55 years. No significant differences were observed according to gender. However, better levels of quitting were observed in the higher age and higher score on the motivation scale. CONCLUSIONS: · No differences were observed in the quitting rates based on gender. · The success of quitting attempts increases with age and with high motivation

The Spanish Society of Pulmonology and Thoracic Surgery Lung Cancer Cooperative Group-II registry. A descriptive study.

INTRODUCTION AND OBJECTIVES: The seventh edition of the TNM classification, together with undeniable advantages, has limitations. The International Association for the Study of Lung Cancer (IASLC) Staging Committee has designed an international prospective study to improve this classification. A group of thoracic surgeons and pulmonologists was established in the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Oncology area, and created a registry of new lung cancer (LC) cases to participate in this project. The aim of this paper is to describe the main characteristics of the patients included. MATERIALS AND METHODS: Prospective, observational, multicentre, multiregional data collection (epidemiological, clinical, therapeutic and, especially, anatomical extension) study, according to the IASLC protocol, to analyse its prognostic value. RESULTS: Two thousand, four hundred and nineteen patients (83.6% men) from 28 hospitals were included. Ninety-six percent of the men and 54% of the women were smokers or ex-smokers. Chest/abdominal computed tomography (CT) scanning was performed in over 90% and positron emission tomography (PET)/CT scanning in 51.5% of cases. Among the 1035 patients who underwent surgery, 77% had early stages (ia to iib), and 61.6% of those treated using other methods had stage iv. Respiratory comorbidity was higher in men (47.9% versus 21.4%). The most common histological subtype was adenocarcinoma (34%), especially in non-smoking women (69.5%). CONCLUSIONS: The proportion of women and adenocarcinomas, as well as those resected at an early stage, increased among LC cases in Spain.